Gene · 1645
Papers1,803
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,803
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Proteome-Wide Ligand and Target Discovery by Using Covalent Probes and Natural Products. | J Med Chem | 2025 | 40994137 | PubTator, text mining | PubMed |
| Posidonia oceanica Extract Inhibits VEGF-Induced Angiogenic and Oxidative Responses in Human Endothelial Colony-Forming Cells. | J Xenobiot | 2025 | 40981364 | PubTator, text mining | PubMed |
| Proteome Differences in Smooth Muscle Cells from Diabetic and Non-Diabetic Abdominal Aortic Aneurysm Patients Reveal Metformin-Induced Mechanisms. | Med Sci (Basel) | 2025 | 40981182 | PubTator, text mining | PubMed |
| Efficacy and mechanism of high-purity HAMCC combined with CGF in promoting the repair of radiation-induced skin and soft tissue damage. | PLoS One | 2025 | 40924776 | PubTator, text mining | PubMed |
| Metabolic activation of flunitrazepam via nitroreduction mediated by aldo-keto reductase 1C3. | Drug Metab Dispos | 2025 | 40885108 | PubTator, text mining | PubMed |
| Recapitulating dengue virus infection with human pluripotent stem cell-derived liver organoids for antiviral screening. | Nat Commun | 2025 | 40877283 | PubTator, text mining | PubMed |
| Targeting FAM111B attenuates mitophagy and increases the sensitivity to lenvatinib treatment by increasing MFN2 stability in hepatocellular carcinoma. | Cell Death Dis | 2025 | 40855067 | PubTator, text mining | PubMed |
| Translocator protein deficiency blocks the ferroptosis of malignant peripheral nerve sheath tumors through glutathione peroxidase 4. | Front Cell Neurosci | 2025 | 40842566 | PubTator, text mining | PubMed |
| Integrative analysis of KEAP1/NFE2L2 alterations across 3600+ tumors reveals an NRF2 expression signature as a prognostic biomarker in cancer. | NPJ Precis Oncol | 2025 | 40825842 | PubTator, text mining | PubMed |
| Nobiletin promotes ferroptosis in breast cancer through targeting AKR1C1-mediated ubiquitination and degradation of GPX4. | Phytomedicine | 2025 | 40819642 | PubTator, text mining | PubMed |
| Correlation between methyltransferase METTL7B and atherosclerosis. | Arch Biochem Biophys | 2025 | 40750092 | PubTator, text mining | PubMed |
| Upregulation of 15-Hydroxyprostaglandin Dehydrogenase by Celecoxib to Reduce Pain After Laparoendoscopic Single-Site Surgery (POPCORN Trial): A Randomized Controlled Trial. | Biomedicines | 2025 | 40722854 | PubTator, text mining | PubMed |
| Chemical proteomics reveals hesperidin and hesperetin as AKR1C1/2 inhibitors with chemosensitization effect. | Chem Commun (Camb) | 2025 | 40717519 | PubTator, text mining | PubMed |
| The targeting of AKR1C1 synergizes with gefitinib via the STAT3 signaling pathway in EGFR-mutated NSCLC. | Genes Dis | 2025 | 40687611 | PubTator, text mining | PubMed |
| Bioinformatics analysis and experimental validation of ferroptosis genes in heart failure and atrial fibrillation. | Front Genet | 2025 | 40672390 | PubTator, text mining | PubMed |
| SOX4 promotes triple-negative breast cancer progression by promoting SRPX2 transcription to regulate AKR1C1. | J Mol Histol | 2025 | 40663167 | PubTator, text mining | PubMed |
| The inhibition of prostaglandin production during ovulation by exposure to a phthalate mixture is circumvented by cAMP analogue supplementation in a human granulosa cell model. | Reprod Toxicol | 2025 | 40456493 | PubTator, text mining | PubMed |
| Radioactive Tracing of Testosterone Reveals Minimal Formation of 5α-DHT in SGBS Cells and Human Primary Adipocytes. | J Endocr Soc | 2025 | 40421431 | PubTator, text mining | PubMed |
| Rewiring lipid metabolism to enhance immunotherapy efficacy in melanoma: a frontier in cancer treatment. | Front Oncol | 2025 | 40376583 | PubTator, text mining | PubMed |
| The identification and validation of histone acetylation-related biomarkers in depression disorder based on bioinformatics and machine learning approaches. | Front Neurosci | 2025 | 40370665 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1645/papers?page=4